Investor Relations
Mar 21, 2019
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial MORE >>
Feb 27, 2019
OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2019
OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019 MORE >>
Feb 05, 2019
OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>

SEC Filing Details

Document Details

Filing Date
Oct 14, 1998
Document Date
Oct 14, 1998
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
3,4,5
Company
OPKO Health, Inc.
Filer
MEYERS BRUCE